These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20510240)

  • 1. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.
    Karmakar S; Kay J; Gravallese EM
    Rheum Dis Clin North Am; 2010 May; 36(2):385-404. PubMed ID: 20510240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.
    Kitaura H; Kimura K; Ishida M; Kohara H; Yoshimatsu M; Takano-Yamamoto T
    Clin Dev Immunol; 2013; 2013():181849. PubMed ID: 23762085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
    Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
    Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts.
    Pathak JL; Bravenboer N; Verschueren P; Lems WF; Luyten FP; Klein-Nulend J; Bakker AD
    Osteoporos Int; 2014 Oct; 25(10):2453-63. PubMed ID: 25027107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
    Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
    J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast role in the pathogenesis of rheumatoid arthritis.
    Berardi S; Corrado A; Maruotti N; Cici D; Cantatore FP
    Mol Biol Rep; 2021 Mar; 48(3):2843-2852. PubMed ID: 33774802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid Arthritis in the View of Osteoimmunology.
    Auréal M; Machuca-Gayet I; Coury F
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis.
    Schett G
    Mod Rheumatol; 2017 Mar; 27(2):193-197. PubMed ID: 28051887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.
    Shim JH; Stavre Z; Gravallese EM
    Calcif Tissue Int; 2018 May; 102(5):533-546. PubMed ID: 29204672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-mediated bone destruction in rheumatoid arthritis.
    Jung SM; Kim KW; Yang CW; Park SH; Ju JH
    J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
    Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
    Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas/S1P
    Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone effects of biologic drugs in rheumatoid arthritis.
    Corrado A; Neve A; Maruotti N; Cantatore FP
    Clin Dev Immunol; 2013; 2013():945945. PubMed ID: 23864880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.